China Traditional Chinese Medicine Holdings Co (HK:0570) has released an update.
China Traditional Chinese Medicine Holdings Co. Limited has announced that their Danggui Buxue Tang Granules, a traditional Chinese medicine compound, has been granted marketing approval by the National Medical Products Administration. This approval marks a significant technological advancement for the company in the field of traditional Chinese medicine. The company intends to continue fostering innovation in this area, aiming to expand the clinical application of its traditional Chinese medicines and support public health.
For further insights into HK:0570 stock, check out TipRanks’ Stock Analysis page.
